| Can you use before/after photos in aesthetic clinic advertising? |
Not allowed
Restricted under KKM/MOH Aesthetic Medical Practice Guidelines — use educational/process visuals or practitioner credentials instead.
Verified 2026-07-15 · source |
Not allowed
Prohibited under Regulation 5 of the Healthcare Services (Advertisement) Regulations 2021, with a narrow exception only for images shown privately during an actual consultation.
Verified 2026-07-27 · source |
Not allowed
AHPRA guidance prohibits before/after imagery that creates an unrealistic expectation of benefit for higher-risk cosmetic procedures.
Verified 2026-07-27 · source |
Not allowed
Before/after comparisons implying treatment effect are prohibited, bundled with the testimonials restriction under UMAO.
Verified 2026-07-27 · source |
Unverified
No distinct before/after-imagery rule found in the sourced TFDA/Fair Trade Act/Consumer Protection Act rule set — the closest adjacent rule (improper-means-testimonial) covers testimonial framing, not photographic before/after comparisons specifically. Not answered rather than guessed.
|
| Can you use patient testimonials in clinic advertising? |
Not allowed
Testimonials about clinical/aesthetic outcomes are restricted under KKM/MOH and MDC guidance — hard to verify and treated as an outcome claim.
Verified 2026-07-15 · source |
Not allowed
Not allowed by default under Regulation 14; the narrow exception is a genuine, unpaid, unedited review appearing only on your own premises/website/social channels — never paid, influencer, solicited or reproduced testimonials.
Verified 2026-07-27 · source |
Not allowed
National Law s133 prohibits testimonials in health service advertising outright; AHPRA's Sept 2025 cosmetic-procedure guidelines extended this explicitly to re-shared patient stories and influencer testimonials.
Verified 2026-07-27 · source |
Not allowed
Patient testimonials and recommendations are prohibited, the same restriction pattern as MY/SG under UMAO's own framing.
Verified 2026-07-27 · source |
Restricted / conditional
Pharmaceutical Affairs Act Article 68 prohibits publicising a medicament via an interview/news report or using another person's name to warrant efficacy; Article 70 treats such framing as an advertisement in its own right, needing the same prior approval as a direct ad.
Verified 2026-07-31 · source |
| Can you advertise a specific treatment price? |
Not allowed
Price-based inducements ("from RMx", limited-time discounts) for medical/aesthetic services are restricted — they can trivialise a clinical decision. Discuss pricing privately after assessment.
Verified 2026-07-15 · source |
Not allowed
Regulation 5 requires exact, final prices — no "from", no crossed-out usual price, no percentage discounts, no time-limited pricing language. Payment plans may only be disclosed at point of payment.
Verified 2026-07-27 · source |
Restricted / conditional
Not banned outright, but any discount/gift/inducement tied to a regulated health service must clearly state its terms and conditions in plain language — manufactured urgency around a clinical decision is separately discouraged.
Verified 2026-07-27 · source |
Unverified
No distinct price-advertising rule found in the sourced UMAO rule set (which focuses on disease/treatment claims and testimonials) — not answered rather than guessed.
|
Unverified
No distinct price-advertising rule found in the sourced TFDA/Fair Trade Act/Consumer Protection Act rule set — not answered rather than guessed.
|
| Can you run discounts, gifts or package promotions for clinic treatments? |
Not allowed
Contests, gifts and manufactured urgency ("limited slots today") to drive medical bookings are restricted under KKM/MOH and MDC guidance.
Verified 2026-07-15 · source |
Not allowed
Regulation 15 prohibits advertising any gift, freebie, lucky draw or voucher tied to purchasing a healthcare service; referral-reward programmes may only be disclosed at point of payment.
Verified 2026-07-27 · source |
Restricted / conditional
Same rule as price advertising — a discount/gift/time-limited inducement must clearly state its terms, not be banned outright, but manufactured urgency around a clinical decision is discouraged.
Verified 2026-07-27 · source |
Unverified
No distinct discount/package-promotion rule found in the sourced UMAO rule set — not answered rather than guessed.
|
Unverified
No distinct discount/package-promotion rule found in the sourced rule set — not answered rather than guessed.
|
| Can you use "specialist"/superlative claims ("best", "#1", "most advanced")? |
Not allowed
Unverifiable superlatives are discouraged under KKM/MOH guidance; MDC guidance additionally restricts a "specialist" title unless backed by the matching recognised qualification.
Verified 2026-07-15 · source |
Not allowed
Regulation 5 bans laudatory/superlative terms even when truthful — the rule targets the promotional framing itself, not whether the claim is provable.
Verified 2026-07-27 · source |
Not allowed
Since 1 July 2023, the title "surgeon" (incl. "cosmetic surgeon") is legally protected — only a practitioner with specialist registration in surgery, obstetrics/gynaecology or ophthalmology may use it; a cosmetic-surgery endorsement alone does not qualify.
Verified 2026-07-27 · source |
Not allowed
Exaggerated or superlative terms ("best", "only", "most effective", "guaranteed success") are prohibited outright.
Verified 2026-07-27 · source |
Restricted / conditional
Fair Trade Act Article 21 prohibits false or misleading representations able to affect a trading decision; the Fair Trade Commission's own guidelines give superlative terms ("No. 1", "champion") used without probative data as a typical violation example.
Verified 2026-07-31 · source |
| Can an influencer promote a clinic without disclosing it's paid? |
Unverified
The sourced KKM/MDC rule sets restrict patient testimonials generally but do not contain a distinct influencer-specific disclosure rule — not answered rather than guessed.
|
Not allowed
Regulation 14's testimonial exception explicitly excludes paid reviews and influencer endorsements — an influencer testimonial for a healthcare service is restricted outright, disclosure or not.
Verified 2026-07-27 · source |
Not allowed
AHPRA's Sept 2025 guidelines specifically strengthened the ban on influencer/social-media testimonials for cosmetic procedures — applies even when the practitioner didn't write the content and only re-shared or boosted it.
Verified 2026-07-27 · source |
Unverified
The sourced UMAO rule set bans testimonials generally but has no distinct influencer-disclosure rule — not answered rather than guessed.
|
Unverified
The sourced rule set's testimonial rule (Article 68/70) covers interview/news-report framing but not influencer-disclosure specifically — not answered rather than guessed.
|
| Can you name a specific prescription product (e.g. a Botox brand) in an ad? |
Not allowed
Advertising scheduled/prescription products to the public is restricted under the Medicines (Advertisement & Sale) Act 1956 — refer to the treatment category in general terms only.
Verified 2026-07-15 · source |
Not allowed
Prescription-Only Medicines and Professional-Use-Only devices — explicitly including botulinum toxin (Botox) and hyaluronic-acid dermal fillers as named examples — may not be advertised to the public at all.
Verified 2026-07-27 · source |
Not allowed
The Therapeutic Goods Act 1989 prohibits advertising prescription-only medicines to the public, with very limited exceptions — this includes naming a specific prescription injectable or weight-loss medication brand.
Verified 2026-07-27 · source |
Unverified
No distinct prescription-product-naming rule found in the sourced UMAO rule set — not answered rather than guessed.
|
Restricted / conditional
Not a naming-specific rule, but the closest sourced match: the TFDA has stated off-label promotion is not allowed (Letter No. 1101460212), upheld in a Taichung District Court case fining NT$200,000 for advertising a treatment beyond its approved indication under Pharmaceutical Affairs Act Article 68.
Verified 2026-07-31 · source |
| Does a clinic treatment purchase require a cooling-off period? |
Unverified
Not covered by the sourced KKM/MDC advertising-content rule sets — a cooling-off requirement (if any) would sit under general consumer-contract law, not clinic advertising rules, and was not researched for this page. Not answered rather than guessed.
|
Unverified
Not covered by the sourced Healthcare Services (Advertisement) Regulations rule set, which governs ad content, not contract/consumer-protection cooling-off rights. Not answered rather than guessed.
|
Unverified
Not covered by the sourced AHPRA/TGA advertising-content rule set. Not answered rather than guessed.
|
Unverified
Not covered by the sourced UMAO rule set. Not answered rather than guessed.
|
Unverified
Not covered by the sourced TFDA/Fair Trade Act rule set — Consumer Protection Act cooling-off provisions (if applicable) govern direct-sales contracts generally and were not researched for this page. Not answered rather than guessed.
|